Haritz Moreno

1.2k total citations
9 papers, 660 citations indexed

About

Haritz Moreno is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Haritz Moreno has authored 9 papers receiving a total of 660 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Immunology and 2 papers in Oncology. Recurrent topics in Haritz Moreno's work include Immunotherapy and Immune Responses (3 papers), Complement system in diseases (2 papers) and Cancer Immunotherapy and Biomarkers (2 papers). Haritz Moreno is often cited by papers focused on Immunotherapy and Immune Responses (3 papers), Complement system in diseases (2 papers) and Cancer Immunotherapy and Biomarkers (2 papers). Haritz Moreno collaborates with scholars based in Spain, United States and Saudi Arabia. Haritz Moreno's co-authors include Noemí Boqué, Fermı́n I. Milagro, J. Alfredo Martínéz, Carlos Ortíz-de-Solórzano, Javier Campión, Arrate Muñoz‐Barrutia, Fernando Lecanda, Silvestre Vicent, Sergio Ortiz‐Espinosa and Luis M. Montuenga and has published in prestigious journals such as Gastroenterology, American Journal of Respiratory and Critical Care Medicine and Journal of Lipid Research.

In The Last Decade

Haritz Moreno

9 papers receiving 654 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Haritz Moreno Spain 7 214 192 190 158 111 9 660
Carine Valle France 13 273 1.3× 298 1.6× 165 0.9× 163 1.0× 90 0.8× 20 728
Long Cui China 12 281 1.3× 76 0.4× 223 1.2× 118 0.7× 176 1.6× 27 762
Yang Mei China 20 490 2.3× 237 1.2× 165 0.9× 104 0.7× 87 0.8× 51 987
Su Myung Jung South Korea 15 451 2.1× 234 1.2× 165 0.9× 171 1.1× 162 1.5× 27 870
Karin Rothgiesser Switzerland 7 279 1.3× 132 0.7× 122 0.6× 175 1.1× 111 1.0× 12 693
Elisa Manieri Spain 10 292 1.4× 103 0.5× 79 0.4× 126 0.8× 186 1.7× 12 629
Ángela Vinué Spain 14 242 1.1× 97 0.5× 179 0.9× 157 1.0× 45 0.4× 24 650
Núria Tarrats United Kingdom 12 337 1.6× 222 1.2× 133 0.7× 224 1.4× 52 0.5× 13 763
Joanna R. DiSpirito United States 12 388 1.8× 256 1.3× 517 2.7× 234 1.5× 125 1.1× 14 1.0k
Yuri Shimoda Japan 7 386 1.8× 184 1.0× 164 0.9× 218 1.4× 47 0.4× 10 708

Countries citing papers authored by Haritz Moreno

Since Specialization
Citations

This map shows the geographic impact of Haritz Moreno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haritz Moreno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haritz Moreno more than expected).

Fields of papers citing papers by Haritz Moreno

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haritz Moreno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haritz Moreno. The network helps show where Haritz Moreno may publish in the future.

Co-authorship network of co-authors of Haritz Moreno

This figure shows the co-authorship network connecting the top 25 collaborators of Haritz Moreno. A scholar is included among the top collaborators of Haritz Moreno based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haritz Moreno. Haritz Moreno is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Otero, Irene, Haritz Moreno, Paula Aldaz, et al.. (2022). The Regulators of Peroxisomal Acyl-Carnitine Shuttle CROT and CRAT Promote Metastasis in Melanoma. Journal of Investigative Dermatology. 143(2). 305–316.e5. 17 indexed citations
2.
Rodríguez‐Nogales, Carlos, Haritz Moreno, Carolina Zandueta, et al.. (2020). Combinatorial Nanomedicine Made of Squalenoyl-Gemcitabine and Edelfosine for the Treatment of Osteosarcoma. Cancers. 12(7). 1895–1895. 9 indexed citations
3.
Ajona, Daniel, Carolina Zandueta, Leticia Corrales, et al.. (2018). Blockade of the Complement C5a/C5aR1 Axis Impairs Lung Cancer Bone Metastasis by CXCL16-mediated Effects. American Journal of Respiratory and Critical Care Medicine. 197(9). 1164–1176. 72 indexed citations
4.
Ajona, Daniel, Sergio Ortiz‐Espinosa, Haritz Moreno, et al.. (2017). A Combined PD-1/C5a Blockade Synergistically Protects against Lung Cancer Growth and Metastasis. Cancer Discovery. 7(7). 694–703. 187 indexed citations
5.
Ajona, Daniel, et al.. (2017). MA09.01 Dual Blockade of PD-1 and C5a/C5aR Synergistically Protects against Non-Small Cell Lung Cancer Tumor Growth. Journal of Thoracic Oncology. 12(1). S391–S391. 1 indexed citations
6.
Perurena, Naiara, Carolina Zandueta, Susana Martínez-Canarias, et al.. (2017). EPCR promotes breast cancer progression by altering SPOCK1/testican 1-mediated 3D growth. Journal of Hematology & Oncology. 10(1). 23–23. 19 indexed citations
7.
Argemí, Josepmaria, Theresia R. Kress, Cristina Bértolo, et al.. (2017). X-box Binding Protein 1 Regulates Unfolded Protein, Acute-Phase, and DNA Damage Responses During Regeneration of Mouse Liver. Gastroenterology. 152(5). 1203–1216.e15. 41 indexed citations
8.
Ajona, Daniel, Carolina Zandueta, Leticia Corrales, et al.. (2017). P3.07-007 Blockade of the Complement C5a/C5aR1 Axis Impairs Lung Cancer Bone Metastasis. Journal of Thoracic Oncology. 12(11). S2300–S2300. 1 indexed citations
9.
Campión, Javier, Arrate Muñoz‐Barrutia, Noemí Boqué, et al.. (2012). Adiposoft: automated software for the analysis of white adipose tissue cellularity in histological sections. Journal of Lipid Research. 53(12). 2791–2796. 313 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026